35 results
DEFA14A
CELL
Bruker Cellular Analysis, Inc.
1 Apr 21
Additional proxy soliciting materials
12:00am
previously with preliminary materials.
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing
10-Q
2020 Q2
CELL
Bruker Cellular Analysis, Inc.
25 Aug 20
Quarterly report
4:29pm
incremental legal, consulting, banking and accounting fees relating to equity offerings, are capitalized and will be offset against proceeds upon … partially offset by an increase from sales in service warranty and application support arrangements.
Product revenue increased by $2.5 million, or 14
CORRESP
ptqoaw8
6 Jul 20
Correspondence with SEC
12:00am
S-1
EX-10.11
z9dv 7cajtsubadri
26 Jun 20
IPO registration
4:31pm
DRS/A
EX-10.11
ma92 ehdnxynr
12 Jun 20
Draft registration statement (amended)
12:00am
S-1
EX-10.11
rguoag pg0
26 Jun 20
IPO registration
4:31pm
DRS/A
EX-10.11
dyphoin
12 Jun 20
Draft registration statement (amended)
12:00am
10-K
tfkmkb9jkf1aw7
12 Mar 21
Annual report
5:17pm
DRS/A
rdac9lp9
12 Jun 20
Draft registration statement (amended)
12:00am
S-1/A
EX-10.12
lm5uiamg6gray9vi
13 Jul 20
IPO registration (amended)
6:07am